NORMAL SITUATION

PHARMA SERVICES

Export PDF

Financial year 2021 · closed on 31/12/2021

Net result

-332,4 €

+0.8% YoY

Gross margin

29,4 k €

-22.8% YoY

Equity

97,9 k €

-0.3% YoY

Workforce

1,3 ETP

+18.2% YoY

Company — Normal situation.

What does PHARMA SERVICES do?

PHARMA SERVICES is a company registered in Belgium. It employs on average 1,3 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0471.348.140

Legal form

Private company with limited liability

Contributed capital

18 550,00 €

Latest accounts

31/12/2021

Average workforce

1,3 ETP

Joint committees (3)

Signals

Solid equityGood liquidityHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	29,4 k €	-22.8%	38,1 k €	-9.6%	42,2 k €	-20.3%	52,9 k €	+8.4%	48,8 k €	-14.9%	57,4 k €	-0.5%	57,7 k €	+45.4%	39,7 k €	-11.6%	44,9 k €	-43.1%	78,8 k €	+761%	9,1 k €	-74.7%	36,2 k €	-4.0%	37,7 k €	-45.6%	69,3 k €	+43.5%	48,3 k €
EBITDA	-41,8 €	+56.3%	-95,6 €	-106%	1,6 k €	-86.0%	11,1 k €	+4.1%	10,7 k €	-50.9%	21,7 k €	-41.6%	37,1 k €	+1109%	3,1 k €	-72.2%	11 k €	-43.6%	19,6 k €	+195%	-20,6 k €	-297%	10,5 k €	-40.3%	17,5 k €	+257%	-11,2 k €	-172%	15,4 k €
Operating result	-41,8 €	+56.3%	-95,6 €	-106%	1,6 k €	-86.0%	11,1 k €	+4.1%	10,7 k €	-50.9%	21,7 k €	-41.6%	37,1 k €	+1109%	3,1 k €	-72.2%	11 k €	-43.6%	19,6 k €	+195%	-20,6 k €	-353%	8,1 k €	-44.3%	14,6 k €	+204%	-14,1 k €	-213%	12,5 k €
Net result	-332,4 €	+0.8%	-334,9 €	-161%	553 €	-94.6%	10,3 k €	-3.4%	10,6 k €	-51.0%	21,7 k €	-41.4%	37 k €	+1075%	3,1 k €	-72.5%	11,5 k €	-45.7%	21,1 k €	+205%	-20,2 k €	-363%	7,7 k €	-51.5%	15,8 k €	+229%	-12,3 k €	-197%	12,7 k €
Balance sheet
Equity	97,9 k €	-0.3%	98,2 k €	-0.3%	98,6 k €	+0.6%	98 k €	+11.7%	87,8 k €	-47.9%	168,6 k €	+14.7%	147 k €	+33.3%	110,3 k €	+2.9%	107,1 k €	+12.0%	95,7 k €	+28.3%	74,6 k €	-21.3%	94,7 k €	+8.8%	87,1 k €	+22.2%	71,3 k €	-14.7%	83,5 k €
Total assets	107,2 k €	-0.4%	107,6 k €	-0.8%	108,4 k €	-1.5%	110,1 k €	-41.4%	187,7 k €	+5.9%	177,3 k €	+5.0%	168,9 k €	+34.9%	125,3 k €	+3.1%	121,4 k €	+5.7%	114,9 k €	+28.9%	89,2 k €	-14.8%	104,7 k €	+7.1%	97,8 k €	+11.0%	88,1 k €	-13.3%	101,6 k €
Cash	15,7 k €	-65.2%	45 k €	-30.8%	65 k €	-25.8%	87,6 k €	-43.5%	155 k €	+129%	67,7 k €	+418%	13,1 k €	-26.5%	17,8 k €	-39.8%	29,5 k €	-42.4%	51,2 k €	-22.3%	65,9 k €	-13.8%	76,4 k €	+2.6%	74,5 k €	+15.6%	64,4 k €	-23.6%	84,2 k €
Debts	9,3 k €	-0.8%	9,3 k €	-5.1%	9,8 k €	-18.2%	12 k €	-87.9%	99,9 k €	+1047%	8,7 k €	-60.3%	22 k €	+46.5%	15 k €	+4.7%	14,3 k €	-25.7%	19,3 k €	+31.8%	14,6 k €	+46.3%	10 k €	+8.2%	9,2 k €	-45.2%	16,8 k €	-6.9%	18,1 k €
Other
Workforce	1,3 ETP	+18.2%	1,1 ETP	0.0%	1,1 ETP		–		–		–		1,1 ETP	+10.0%	1,0 ETP	0.0%	1,0 ETP	+150%	0,4 ETP	0.0%	0,4 ETP	0.0%	0,4 ETP	0.0%	0,4 ETP	-66.7%	1,2 ETP	+140%	0,5 ETP

Governance

Board of directors

Seen on filing of 31/12/2021 · 1 active · 11 ended

Active mandates

GESTIFAR

Director · since 30 septembre 2015 · 0441.670.890

Represented by Jean - Christophe Vanderelst

Active

Ended mandates

GESTIFAR

Manager · since 30 septembre 2015 · 0441.670.890

Represented by Jean - Christophe Vanderelst

Ended

Catherine BROWET

Director · since 29 juin 2012 · until 19 juin 2017

Ended

Catherine BROWET

Director · since 29 juin 2012

Ended

Jean Christophe VANDERELST

Director · since 29 juin 2012

Ended

Annual accounts

Full financial information

	2021	2020	2019	2018	2017	2016
Type of account	Abridged model	Abridged model	Abridged model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017	01/01/2016
Closing of the financial year	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017	31/12/2016
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/06/2022	19/08/2021	04/09/2020	23/07/2019	23/08/2018	18/08/2017
General meeting	24/02/2022	21/06/2021	15/06/2020	17/06/2019	18/06/2018	19/06/2017
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2021	24/02/2022	28/06/2022	French	PDF
Abridged model	31/12/2020	21/06/2021	19/08/2021	French	PDF
Abridged model	31/12/2019	15/06/2020	04/09/2020	French	PDF
Micro model	31/12/2018	17/06/2019	23/07/2019	French	PDF
Micro model	31/12/2017	18/06/2018	23/08/2018	French	PDF
Micro model	31/12/2016	19/06/2017	18/08/2017	French	PDF
Abridged model	31/12/2015	20/06/2016	23/08/2016	French	PDF
Abridged model	31/12/2014	15/06/2015	17/06/2015	French	PDF
Abridged model	31/12/2013	16/06/2014	18/06/2014	French	PDF
Abridged model	31/12/2012	17/06/2013	27/06/2013	French	PDF
Abridged model	30/06/2011	28/12/2011	12/01/2012	French	PDF
Abridged model	30/06/2010	22/12/2010	01/02/2011	French	PDF
Abridged model	30/06/2009	29/12/2009	02/03/2010	French	PDF
Abridged model	30/06/2008	24/12/2008	18/02/2009	French	PDF
Abridged model	30/06/2007	26/12/2007	08/01/2008	French	PDF
Abridged model	30/06/2006	27/12/2006	26/02/2007	French	PDF
Abridged model	30/06/2005	28/12/2005	30/01/2006	French	PDF
Abridged model	30/06/2004	22/12/2004	28/01/2005	French	PDF
Abridged model	30/06/2003	24/12/2003	24/12/2003	French	PDF
Abridged model	30/06/2002	26/12/2002	16/04/2003	French	PDF
Abridged model	30/06/2001	26/12/2001	19/03/2002	French	PDF

Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2021 · 1 active · 11 ended

Active mandates

GESTIFAR

Director · since 30 septembre 2015 · 0441.670.890

Represented by Jean - Christophe Vanderelst

Active

Ended mandates

GESTIFAR

Manager · since 30 septembre 2015 · 0441.670.890

Represented by Jean - Christophe Vanderelst

Ended

Catherine BROWET

Director · since 29 juin 2012 · until 19 juin 2017

Ended

Catherine BROWET

Director · since 29 juin 2012

Ended

Jean Christophe VANDERELST

Director · since 29 juin 2012

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2021
Annual accounts 2021-332,4 €↑
2020
Annual accounts 2020-334,9 €↓
2019
Annual accounts 2019553 €↓
2018
Annual accounts 201810,3 k €↓
2017
Annual accounts 201710,6 k €↓
2016
Annual accounts 201621,7 k €↓
2015
Annual accounts 201537 k €↑
2014
Annual accounts 20143,1 k €↓
2013
Annual accounts 201311,5 k €↓
2012
Annual accounts 201221,1 k €↑
2011
Annual accounts 2011-20,2 k €↓
2010
Annual accounts 20107,7 k €↓
2009
Annual accounts 200915,8 k €↑
2008
Annual accounts 2008-12,3 k €↓
2007
Annual accounts 200712,7 k €

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMA SERVICES

Overview

What does PHARMA SERVICES do?

Trend over 15 financial years

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Similar companies

Similar companies

Timeline